During the past decade, Azienda Ospedaliera San Giuseppe Moscati conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 8 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera San Giuseppe Moscati" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Canadian Cancer Trials Group" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Ariad Pharmaceuticals" with 1 trials sponsored and "Incyte Corporation" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera San Giuseppe Moscati" #1 collaborator was "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials as a collaborator, "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator, "BioMérieux" with 1 trials as a collaborator, "Central and Eastern European Oncology Group" with 1 trials as a collaborator and "Chinese Thoracic Oncology Group" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera San Giuseppe Moscati" are "Breast Cancer" (4 trials), "Non-Small Cell Lung Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Carcinoma" (2 trials) and "Advanced Malignancies" (1 trials). Many other conditions were trialed in "Azienda Ospedaliera San Giuseppe Moscati" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera San Giuseppe Moscati" are "Drug" (15 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Docetaxel" (3 trials), "Placebo" (3 trials), "Paclitaxel" (2 trials) and "Trastuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera San Giuseppe Moscati" are 16 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera San Giuseppe Moscati". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Azienda Ospedaliera San Giuseppe Moscati, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera San Giuseppe Moscati, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".